Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esaxerenone to prevent recurrent atrial fibrillation after ablation in hypertensive patients
jRCTs071240092Recruiting
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esaxerenone in Atrial fibrillation (AFib) and hypertension (HTN). Primary endpoint: Time to atrial fibrillation recurrence. Started Jul 2025; status: recruiting.
02
Drugs
esaxerenone
03
Conditions
Atrial fibrillation (AFib)hypertension (HTN)
Beyond the preview
Go deeper on jRCTs071240092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071240092.